Dendritic cell vaccines for glioblastoma fail to complete clinical translation: Bottlenecks and potential countermeasures
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dendritic cell vaccines for glioblastoma fail to complete clinical translation: Bottlenecks and potential countermeasures
Authors
Keywords
-
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 109, Issue -, Pages 108929
Publisher
Elsevier BV
Online
2022-06-12
DOI
10.1016/j.intimp.2022.108929
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glioma targeted therapy: insight into future of molecular approaches
- (2022) Keyang Yang et al. Molecular Cancer
- 90K predicts the prognosis of glioma patients and enhances tumor lysate-pulsed DC vaccine for immunotherapy of GBM in vitro
- (2021) Yu Zeng et al. Aging-US
- The efficacy of dendritic cell vaccine for newly diagnosed glioblastoma: a meta-analysis of randomized controlled studies
- (2021) Zhongtao Liu et al. NEUROCHIRURGIE
- Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma
- (2021) Stephen C. Frederico et al. Frontiers in Oncology
- Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach
- (2021) Chang-Gon Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
- (2021) David N Louis et al. NEURO-ONCOLOGY
- Synergy of nanodiamond–doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells
- (2021) Hua-Zhen Xu et al. JOURNAL OF NANOBIOTECHNOLOGY
- Exosome-Based Vaccines: History, Current State, and Clinical Trials
- (2021) Patrick Santos et al. Frontiers in Immunology
- Personalized Neoantigen-Pulsed DC Vaccines: Advances in Clinical Applications
- (2021) Lin Tang et al. Frontiers in Oncology
- Cancer Vaccines: Promising Therapeutics or an Unattainable Dream
- (2021) Howard Donninger et al. Vaccines
- A Phase I Study of Autologous Dendritic Cell Vaccine Pulsed with Allogeneic Stem-like Cell Line Lysate in Patients with Newly Diagnosed or Recurrent Glioblastoma
- (2021) Jethro L. Hu et al. CLINICAL CANCER RESEARCH
- Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
- (2021) Angeliki Datsi et al. Frontiers in Immunology
- Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors
- (2020) Friedrich Erhart et al. npj Vaccines
- A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma
- (2020) Jeremy D. Rudnick et al. JOURNAL OF CLINICAL NEUROSCIENCE
- A review of glioblastoma immunotherapy
- (2020) Ravi Medikonda et al. JOURNAL OF NEURO-ONCOLOGY
- Adult immuno-oncology: using past failures to inform the future
- (2020) Maryam Rahman et al. NEURO-ONCOLOGY
- Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity
- (2020) Christina A. von Roemeling et al. Nature Communications
- Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma
- (2020) Kristen A Batich et al. CLINICAL CANCER RESEARCH
- Efficacy and safety of dendritic cell vaccines for patients with glioblastoma: A meta-analysis of randomized controlled trials
- (2020) Li Lv et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines
- (2020) Michele Graciotti et al. Vaccines
- Engineered Nanoparticles for Cancer Vaccination and Immunotherapy
- (2020) Marisa E. Aikins et al. ACCOUNTS OF CHEMICAL RESEARCH
- Extracranial metastases in secondary glioblastoma multiforme: a case report
- (2020) Jessica Rossi et al. BMC Neurology
- CD133 mRNA-Loaded Dendritic Cell Vaccination Abrogates Glioma Stem Cell Propagation in Humanized Glioblastoma Mouse Model
- (2020) Angelique Sao-Mai Sy Do et al. Molecular Therapy-Oncolytics
- Clinical implication of cellular vaccine in glioma: current advances and future prospects
- (2020) Yuanliang Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis
- (2020) Jinyang Hu et al. Frontiers in Immunology
- Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged
- (2020) Stefaan W. Van Gool et al. Cancers
- Doxorubicin‐loaded nanoparticle coated with endothelial cells‐derived exosomes for immunogenic chemotherapy of glioblastoma
- (2020) Chao Zhang et al. Bioengineering & Translational Medicine
- Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
- (2019) Ulrich Herrlinger et al. LANCET
- Current State of Immunotherapy for Treatment of Glioblastoma
- (2019) Tresa McGranahan et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials
- (2019) Siddhartha Srivastava et al. Cancers
- Dendritic Cells and Cancer: From Biology to Therapeutic Intervention
- (2019) Wylie et al. Cancers
- A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma
- (2019) Patrick Y. Wen et al. CLINICAL CANCER RESEARCH
- Trial watch: dendritic cell vaccination for cancer immunotherapy
- (2019) Jenny Sprooten et al. OncoImmunology
- Genomic instability and innate immune responses to self-DNA in progeria
- (2019) Susana Gonzalo et al. GeroScience
- PD-L1/PD-1 Axis in Glioblastoma Multiforme
- (2019) Jakub Litak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TIM-3 Regulates CD103 + Dendritic Cell Function and Response to Chemotherapy in Breast Cancer
- (2018) Álvaro de Mingo Pulido et al. CANCER CELL
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial
- (2018) Marion Rapp et al. Trials
- Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme
- (2018) Chia-Ing Jan et al. Frontiers in Immunology
- Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
- (2018) Amber J. Giles et al. Journal for ImmunoTherapy of Cancer
- Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial
- (2018) Yu Yao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials
- (2018) Stefan-Alexandru Artene et al. Scientific Reports
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
- (2017) Susana Inogés et al. Journal of Translational Medicine
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer
- (2017) Charles B Chesson et al. Nanomedicine
- Vaccine-based immunotherapeutic approaches to gliomas and beyond
- (2017) Michael Weller et al. Nature Reviews Neurology
- Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma
- (2017) Joseph P. Antonios et al. NEURO-ONCOLOGY
- Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma
- (2017) Jacob J Mandel et al. NEURO-ONCOLOGY
- Phase I/II Trial of Combination of Temozolomide Chemotherapy and Immunotherapy With Fusions of Dendritic and Glioma Cells in Patients With Glioblastoma
- (2017) Wi Jin Kim et al. NEUROSURGERY
- Combination epidermal growth factor receptor variant III peptide-pulsed dendritic cell vaccine with miR-326 results in enhanced killing on EGFRvIII-positive cells
- (2017) Jianlong Li et al. Oncotarget
- Blocking the CD47-SIRPα axis by delivery of anti-CD47 antibody induces antitumor effects in glioma and glioma stem cells
- (2017) Feng Li et al. OncoImmunology
- Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma
- (2016) Yasuharu Akasaki et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dendritic cell-based immunotherapy
- (2016) Rachel L Sabado et al. CELL RESEARCH
- Migration of dendritic cells to the lymph nodes and its enhancement to drive anti-tumor responses
- (2016) Narges Seyfizadeh et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Advances and challenges: dendritic cell vaccination strategies for glioblastoma
- (2016) Teilo H. Schaller et al. Expert Review of Vaccines
- Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review
- (2016) Lynn S. Ashby et al. World Journal of Surgical Oncology
- Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea
- (2016) Doo-Sik Kong et al. Oncotarget
- TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination
- (2016) M. S. Hsu et al. Cancer Immunology Research
- Dendritic cell–based immunotherapy targeting Wilms’ tumor 1 in patients with recurrent malignant glioma
- (2015) Keiichi Sakai et al. JOURNAL OF NEUROSURGERY
- Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
- (2015) Hideho Okada et al. LANCET ONCOLOGY
- Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
- (2015) Duane A. Mitchell et al. NATURE
- Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy
- (2015) Jashodeep Datta et al. Frontiers in Immunology
- Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay
- (2015) E. Verronèse et al. OncoImmunology
- Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC
- (2014) H. Okada et al. CLINICAL CANCER RESEARCH
- Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma
- (2014) Kristen A Batich et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence
- (2014) A. Radbruch et al. NEURO-ONCOLOGY
- Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
- (2014) Irena Adkins et al. OncoImmunology
- High sensitivity of cancer exome-based CD8 T cell neo-antigen identification
- (2014) Marit M van Buuren et al. OncoImmunology
- The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
- (2013) Miriam Merad et al. Annual Review of Immunology
- Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
- (2013) Einar Osland Vik-Mo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Clinical trials in cellular immunotherapy for brain/CNS tumors
- (2013) Jetan Badhiwala et al. Expert Review of Neurotherapeutics
- Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
- (2012) Surasak Phuphanich et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele
- (2012) Kenichiro Iwami et al. CYTOTHERAPY
- Adjuvant vaccination with melanoma antigen-pulsed dendritic cells in stage III melanoma patients
- (2012) Sergiusz Markowicz et al. MEDICAL ONCOLOGY
- Clinical Application of a Dendritic Cell Vaccine Raised Against Heat-Shocked Glioblastoma
- (2011) X. Jie et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Appropriate end-points for right results in the age of antiangiogenic agents: Future options for phase II trials in patients with recurrent glioblastoma
- (2011) A.A. Brandes et al. EUROPEAN JOURNAL OF CANCER
- Cotransfection of Poly(I
- (2011) Yasuharu Akasaki et al. JOURNAL OF IMMUNOTHERAPY
- Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma
- (2011) Ning Bu et al. JOURNAL OF NEURO-ONCOLOGY
- Adjuvant Immunotherapy with Whole-Cell Lysate Dendritic Cells Vaccine for Glioblastoma Multiforme: A Phase II Clinical Trial
- (2011) Der-Yang Cho et al. World Neurosurgery
- Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines
- (2011) Genevieve M. Weir et al. Cancers
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
- (2009) J. H. Sampson et al. MOLECULAR CANCER THERAPEUTICS
- The cancer vaccine roller coaster
- (2009) Bruce Goldman et al. NATURE BIOTECHNOLOGY
- Antigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated Antigens
- (2009) Qijin Xu et al. STEM CELLS
- Vaccination Elicits Correlated Immune and Clinical Responses in Glioblastoma Multiforme Patients
- (2008) C. J. Wheeler et al. CANCER RESEARCH
- Postoperative Adjuvant Dendritic Cell-Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme
- (2008) S. De Vleeschouwer et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started